MED 8730 Electives Assessment Plan Class of 2025

MED 8730: Electives
Academic Year 2024-2025
Class of 2025

Assessment Plan

Electives are offered in two to four week blocks in approved areas of study for a maximum of twelve weeks.

Entrustable Professional Activities (EPAs)
EPA 1: Obtain a history and perform a physical examination adapted to the patient’s clinical situation.
EPA 2: Formulate and justify a prioritized differential diagnosis.
EPA 3: Formulate an initial plan of investigation based on the diagnostic hypotheses.
EPA 4: Interpret and communicate results of common diagnostic and screening tests.
EPA 5: Formulate, communicate and implement management plans.EPA 6: Present oral and written reports that document a clinical encounter.
EPA 7: Provide and receive the handover in transitions of care.
EPA 8: Recognize a patient requiring urgent or emergent care, provide initial management and seek help.
EPA 9: Communicate in difficult situations.
EPA 10: Contribute to a culture of safety and improvement.
EPA 11: Perform general procedures of a physician.
EPA 12: Educate patients on disease management, health promotion and preventative medicine.
EPA 13: Collaborate as a member of an interprofessional team.
EPA 14: Incorporate the relevant social determinants of health (SDoH) and cultural safety in relation to patient’s illness and management planning.

Course Structure
The course includes 12 weeks to be completed after MED 8710 Core Experiences. Minimum 2 week duration per elective.  Can be completed locally, nationally or internationally on approval by the UGME office.

As outlined in the AFMC Student Electives Diversification Policy, learner elective opportunities cannot exceed a maximum of eight weeks in any single entry-level discipline. An entry-level discipline is an Entry Route in the PGY-1 (R1) match. Each of these entry-level disciplines leads to specialty certification with either the RCPSC or the CCFP. Electives in subspecialties that are part of a PGY-3 (R3) match (such as the subspecialties in Internal Medicine and Pediatrics) are counted as separate disciplines. As such, electives in these subspecialties do not count towards the 8-week maximum in the general specialty.

To be set by the learner specific to a discipline of choice and specific to EPAs of choice to ensure further individual development. For research electives, a learner may additionally choose non-EPA based objectives based on their individual research project. Specific objectives or EPA's may be specified at the discretion of the Phase 4 Management Team in specific cases based on a particular learner's performance in MED 8710: Core Experiences.

In Training Assessment Report (ITAR)
Assessment to be linked to customized objectives above.

Course Success Criteria

To pass the course, a learner must:

  • Obtain an overall rating of performance as appropriate for this level of training in the ITAR for all elective rotations
  • Have no outstanding concerns with professionalism

Learners will receive their grades from the Undergraduate Medical Education (UGME) office via One45.

Original work, completed wholly by the learner, is expected to be submitted in this course. The use of an artificial intelligence tool like chatGPT is not permitted.

As outlined in the MD program objectives, the Faculty of Medicine at Memorial University values professionalism as a core competency and a requirement of the MD program. Recognizing that medical learners are developing their professional identity, professionalism lapses will be remediated where possible and appropriate. Unsuccessful remediation will result in failure of the Phase.  Professionalism lapses may render a learner incompatible with continuation in the MD program (as outlined in the Memorial University Calendar Regulation 10.5 Promotion).  

As outlined in Section 10.5.2 and 10.5.3 of the Regulations for the Degree of Doctor of Medicine in the University calendar, learners with a Fail grade in any course cannot be promoted to graduation. Even in the absence of any Fail grades, a learner for whom substantial concerns about performance have been expressed may either be required to repeat the Phase or required to withdraw conditionally or unconditionally.


Version date: March 13, 2023
Reviewed by SAS: April 26, 2023
Approved by UGMS: May 17, 2023